Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07222618 · ClinicalTrials.gov registry record

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

A clinical trial of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting, sponsored by University of California, San Francisco.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT07222618 is a study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 300 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07222618, a study of Multiple Sclerosis and Multiple Sclerosis (MS) - Relapsing-remitting, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly patient-centered, low-burden, low-cost approach. The main question this study aims to answer is: do remotely collected walking and speech videos from a mobile phone match the information investigators can gather from an in person visit? Participants will collect 5 "selfie" videos at baseline, 3 months, 6 months and 12 months (about 15 minutes every 3 months). They will also come in person at baseline, 6 months, and 12 months for in person data collection (about 1 hour per in person visit).

Conditions Studied

Multiple Sclerosis Multiple Sclerosis (MS) - Relapsing-remitting Multiple Sclerosis (MS) Primary Progressive Multiple Sclerosis (MS) Secondary Progressive MS MS (Multiple Sclerosis)

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-10-01
Est. Completion 2028-10-01

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07222618

The ClinicalTrials.gov registry entry for NCT07222618 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (49% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT07222618 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07222618 about?

NCT07222618 is a clinical study titled ""Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS". The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly pa...

What is the current status of trial NCT07222618?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-10-01. Estimated completion is 2028-10-01.

What conditions does trial NCT07222618 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis (MS) Secondary Progressive, MS.

Who is sponsoring clinical trial NCT07222618?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07222618 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Multiple Sclerosis (MS) - Relapsing-remitting

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.